Meta Health Limited (SGX:5DX)
Singapore
· Delayed Price · Currency is SGD 0.0050
0.00 (0.00%)
At close: Apr 24, 2025
Meta Health Income Statement
Financials in millions SGD. Fiscal year is January - December.
Millions SGD. Fiscal year is Jan - Dec.
Fiscal Year | FY 2024 | FY 2023 | FY 2022 | FY 2021 | FY 2020 | 2015 - 2019 |
|---|---|---|---|---|---|---|
Period Ending | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 | Dec '20 Dec 31, 2020 | 2015 - 2019 |
| Revenue | 0.24 | 4.61 | 11.39 | 43.03 | 32.23 | Upgrade
|
| Revenue Growth (YoY) | -94.69% | -59.49% | -73.53% | 33.48% | -29.10% | Upgrade
|
| Cost of Revenue | 0.06 | 3.79 | 9.53 | 22.72 | 17.02 | Upgrade
|
| Gross Profit | 0.19 | 0.83 | 1.86 | 20.3 | 15.21 | Upgrade
|
| Selling, General & Admin | 0.9 | 2.75 | 3.99 | 13.1 | 10.65 | Upgrade
|
| Other Operating Expenses | -0.26 | 0.69 | 1.75 | 4.44 | 3.2 | Upgrade
|
| Operating Expenses | 0.64 | 3.63 | 6.63 | 20.33 | 16.71 | Upgrade
|
| Operating Income | -0.45 | -2.81 | -4.78 | -0.03 | -1.5 | Upgrade
|
| Interest Expense | -0.14 | -0.29 | -0.27 | -0.5 | -0.43 | Upgrade
|
| Interest & Investment Income | 0.01 | 0 | 0 | 0.03 | 0.01 | Upgrade
|
| Currency Exchange Gain (Loss) | 0.01 | -0.04 | -0.39 | -0.37 | -0.09 | Upgrade
|
| Other Non Operating Income (Expenses) | 0 | -0.01 | -0.54 | - | - | Upgrade
|
| EBT Excluding Unusual Items | -0.57 | -3.15 | -5.97 | -0.87 | -2.01 | Upgrade
|
| Impairment of Goodwill | -0.4 | -0.1 | - | -7.05 | - | Upgrade
|
| Gain (Loss) on Sale of Assets | -0 | -0.08 | 0 | 9.83 | 0.08 | Upgrade
|
| Asset Writedown | -0.08 | - | - | -0.69 | - | Upgrade
|
| Legal Settlements | - | - | -1.4 | - | - | Upgrade
|
| Pretax Income | -1.05 | -3.33 | -7.37 | 1.21 | -1.94 | Upgrade
|
| Income Tax Expense | -0 | - | - | -0 | 0.02 | Upgrade
|
| Earnings From Continuing Operations | -1.05 | -3.33 | -7.37 | 1.21 | -1.96 | Upgrade
|
| Earnings From Discontinued Operations | -0.4 | -5.01 | -1.34 | - | - | Upgrade
|
| Net Income to Company | -1.45 | -8.34 | -8.71 | 1.21 | -1.96 | Upgrade
|
| Minority Interest in Earnings | 0.01 | -0.07 | 0.05 | -0.05 | - | Upgrade
|
| Net Income | -1.44 | -8.41 | -8.66 | 1.16 | -1.96 | Upgrade
|
| Net Income to Common | -1.44 | -8.41 | -8.66 | 1.16 | -1.96 | Upgrade
|
| Shares Outstanding (Basic) | 1,057 | 658 | 555 | 414 | 374 | Upgrade
|
| Shares Outstanding (Diluted) | 1,057 | 658 | 555 | 419 | 374 | Upgrade
|
| Shares Change (YoY) | 60.60% | 18.55% | 32.45% | 12.01% | - | Upgrade
|
| EPS (Basic) | -0.00 | -0.01 | -0.02 | 0.00 | -0.01 | Upgrade
|
| EPS (Diluted) | -0.00 | -0.01 | -0.02 | 0.00 | -0.01 | Upgrade
|
| Free Cash Flow | -1.09 | -2.65 | -2.74 | -0.08 | 0.08 | Upgrade
|
| Free Cash Flow Per Share | -0.00 | -0.00 | -0.01 | - | - | Upgrade
|
| Gross Margin | 77.52% | 17.89% | 16.30% | 47.18% | 47.18% | Upgrade
|
| Operating Margin | -182.06% | -60.82% | -41.94% | -0.06% | -4.66% | Upgrade
|
| Profit Margin | -588.50% | -182.25% | -76.02% | 2.70% | -6.08% | Upgrade
|
| Free Cash Flow Margin | -446.35% | -57.46% | -24.07% | -0.19% | 0.26% | Upgrade
|
| EBITDA | -0.44 | -2.78 | -3.56 | 1.31 | -0.03 | Upgrade
|
| EBITDA Margin | -178.43% | -60.22% | -31.25% | 3.03% | -0.08% | Upgrade
|
| D&A For EBITDA | 0.01 | 0.03 | 1.22 | 1.33 | 1.48 | Upgrade
|
| EBIT | -0.45 | -2.81 | -4.78 | -0.03 | -1.5 | Upgrade
|
| EBIT Margin | -182.06% | -60.82% | -41.94% | -0.06% | -4.66% | Upgrade
|
Source: S&P Global Market Intelligence. Standard template. Financial Sources.